REG - Dr. Martens PLC - Block listing Interim Review

Dr MartensAnnouncement

01/04/2022 14:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220401:nRSA0018Ha&default-theme=true

RNS Number : 0018H  Dr. Martens PLC  01 April 2022

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and
provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 1 APRIL 2022

 

 Name of applicant:                                                                DR. MARTENS PLC
 Name of scheme:                                                                   DR. MARTENS PLC'S EMPLOYEE SHARE PLANS
 Period of return:                        From:                                    1 OCTOBER 2021  To:            1 APRIL 2022
 Balance of unallotted securities under scheme(s) from previous return:            N/A
 Plus:  The amount by which the block scheme(s) has been increased since the       1,200,000 SHARES
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         222,600 SHARES
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        977,400 SHARES

 

 Name of contact:              PAUL ROLLING

                               ASSISTANT COMPANY SECRETARY
 Telephone number of contact:  +447584243562

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRSSSFDFEESESL